145 related articles for article (PubMed ID: 25684590)
1. Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance.
Nakashima H; Jiang SX; Sato Y; Hoshi K; Matsumoto T; Nagashio R; Kobayashi M; Matsuo Y; Shiomi K; Hayakawa K; Saegusa M; Satoh Y
Pathol Int; 2015 Apr; 65(4):183-92. PubMed ID: 25684590
[TBL] [Abstract][Full Text] [Related]
2. Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.
Eom DW; Kang GH; Han SH; Cheon GJ; Han KH; Oh HS; Kim JH; Jang HJ; Hong SM
Am J Surg Pathol; 2011 Jan; 35(1):84-91. PubMed ID: 21164291
[TBL] [Abstract][Full Text] [Related]
3. Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.
Matsumoto T; Nagashio R; Ryuge S; Igawa S; Kobayashi M; Fukuda E; Goshima N; Ichinoe M; Jiang SX; Satoh Y; Masuda N; Murakumo Y; Saegusa M; Sato Y
Pathol Int; 2018 Apr; 68(4):232-240. PubMed ID: 29431238
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
6. Colonic micropapillary carcinoma, a recently recognized subtype associated with histological adverse factors: clinicopathological analysis of 15 cases.
Lino-Silva LS; Salcedo-Hernández RA; Caro-Sánchez CH
Colorectal Dis; 2012 Sep; 14(9):e567-72. PubMed ID: 22390187
[TBL] [Abstract][Full Text] [Related]
7. Slug is associated with poor survival in squamous cell carcinoma of the lung.
Merikallio H; T TT; Pääkkö P; Mäkitaro R; Kaarteenaho R; Lehtonen S; Salo S; Salo T; Harju T; Soini Y
Int J Clin Exp Pathol; 2014; 7(9):5846-54. PubMed ID: 25337226
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with micropapillary component.
Zhang Y; Wang R; Cai D; Li Y; Pan Y; Hu H; Wang L; Li H; Ye T; Luo X; Zhang Y; Li B; Shen L; Sun Y; Chen H
J Thorac Oncol; 2014 Dec; 9(12):1772-8. PubMed ID: 25226429
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes.
Lee G; Lee HY; Jeong JY; Han J; Cha MJ; Lee KS; Kim J; Shim YM
Am J Surg Pathol; 2015 May; 39(5):660-6. PubMed ID: 25724001
[TBL] [Abstract][Full Text] [Related]
11. Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis.
Zhang Q; Ming J; Zhang S; Li B; Yin L; Qiu X
Gastric Cancer; 2015 Jan; 18(1):93-9. PubMed ID: 24562421
[TBL] [Abstract][Full Text] [Related]
12. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
[TBL] [Abstract][Full Text] [Related]
13. S100A16 is a Prognostic Marker for Lung Adenocarcinomas.
Saito K; Kobayashi M; Nagashio R; Ryuge S; Katono K; Nakashima H; Tsuchiya B; Jiang SX; Saegusa M; Satoh Y; Masuda N; Sato Y
Asian Pac J Cancer Prev; 2015; 16(16):7039-44. PubMed ID: 26514487
[TBL] [Abstract][Full Text] [Related]
14. Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases.
Fujimoto M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Hirata M; Momose M; Date H; Haga H
Histopathology; 2017 Jan; 70(2):232-241. PubMed ID: 27467545
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.
Hu XG; Chen L; Wang QL; Zhao XL; Tan J; Cui YH; Liu XD; Zhang X; Bian XW
J Clin Pathol; 2016 Apr; 69(4):313-8. PubMed ID: 26483561
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.
Kubouchi Y; Yurugi Y; Wakahara M; Sakabe T; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Histopathology; 2018 Feb; 72(3):490-499. PubMed ID: 28881047
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
[TBL] [Abstract][Full Text] [Related]
18. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
19. High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients.
Zhao C; Li X; Su C; Li J; Cheng N; Ren S; Chen X; Zhou C
Int J Clin Exp Pathol; 2015; 8(3):3104-9. PubMed ID: 26045824
[TBL] [Abstract][Full Text] [Related]
20. Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma.
Nagano T; Ishii G; Nagai K; Ito T; Kawase A; Takahashi K; Nishimura Y; Nishiwaki Y; Ochiai A
Lung Cancer; 2010 Mar; 67(3):282-9. PubMed ID: 19481833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]